search
Back to results

TelemEdiciNe-bAsed Cognitive TherapY for Migraines (TENACITY)

Primary Purpose

Migraine Headache

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TENACITY Telehealth Cognitive Behavioral Therapy for Migraine
Behavioral Usual Care
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Migraine Headache focused on measuring Implementation Science, Telehealth, Cognitive Behavioral Therapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Veteran patients eligible to participate must have:

  • A chronic migraine headache ICD-10 diagnosis;
  • Completion of at least 28 headache diary days;
  • A confirmed frequency of at least 8 headache days per month;
  • A primary complaint of headache

Exclusion Criteria:

Veteran patients not eligible to participate include:

  • Non-Veterans;
  • Veteran patients without a CM headache ICD-10 diagnosis;
  • Veteran patients whose primary pain complaint is not headache;
  • Veteran patients who have received greater than or equal to 90 days of opioid therapy for chronic low back pain from the date of chart screening;
  • Veteran patients who do not speak English;
  • Veteran patients who have a current diagnosis of severe cognitive impairment indicated by clinical provider, medical chart, or Short Portable Mental Status Questionnaire (SPMSQ);
  • Veteran patients who have Post Traumatic headache;
  • Veteran patients who have a diagnosis of cluster headache, other primary headache, post-whiplash headache, secondary headache, or trigeminal autonomic cephalalgia.
  • Any patients currently suffering from a disabling psychiatric illness (as noted by clinician);
  • Veteran patients who self-report Traumatic Brain Injury less than or equal to 1 year before diagnosis of Chronic Migraine, or worsening of Chronic Migraine.
  • Veteran patients who relate daily suicidal ideation within the last 2 weeks as indicated by the PHQ-9 with an answer of "3" to question nine;
  • Veteran patients who have severe depression, as indicated by PHQ-9 score greater than or equal to 20;
  • Veteran patients who are deemed by clinicians who are unable to participate in this trial;
  • Patients who are terminally ill (life expectancy of <12 months as noted by clinician);
  • Patients who are homeless or live in long-term care, nursing home, rehabilitation, or domiciliary services, etc.
  • Veteran patients who decline to or cannot use the Annie App;
  • Veteran patients who decline to or cannot use My HealtheVet secure messaging
  • Veteran patients who have been treated by a HCoE clinical health psychologist in the last two years

Sites / Locations

  • Birmingham VA Medical Center, Birmingham, AL
  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN
  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

TENACITY Telehealth Cognitive Behavioral Therapy for Migraine

Behavioral Usual Care

Arm Description

Six sessions of standardized Cognitive Behavioral Therapy for patients with diagnosed chronic migraine headaches will be delivered by a clinical health psychologist via telehealth platform. All patients have access to a set of standardized educational, headache self-management materials.

Behavioral usual care may include outpatient clinic-based health psychology in the VA or Community Care, or mindfulness sessions with LCSW. Behavioral usual care will be delivered by clinicians for patients with diagnosed chronic migraine.

Outcomes

Primary Outcome Measures

Number of Headache Days in the 30 days Prior to 3-Month Mark
Daily self-reported migraine headaches using a VA text message protocol

Secondary Outcome Measures

Implementation fidelity to the core functions of TENACITY
Degree to which the core components of TENACITY are delivered as intended
Budget Impact Analysis
Costs associated with program implementation

Full Information

First Posted
October 27, 2020
Last Updated
August 4, 2023
Sponsor
VA Office of Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT04613362
Brief Title
TelemEdiciNe-bAsed Cognitive TherapY for Migraines
Acronym
TENACITY
Official Title
TENACITY: TelemEdiciNe-bAsed Cognitive Therapy for Migraine
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
December 1, 2020 (Actual)
Primary Completion Date
May 31, 2023 (Actual)
Study Completion Date
June 30, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goal of this pilot study is to evaluate a bundle of implementation strategies at three Veteran Affairs Medical Centers (VAMCs) to facilitate the referral and adoption of a telehealth based, cognitive behavioral therapy program delivered by Health Psychologists for Veterans with chronic migraine to inform a future fully-powered hybrid type 2 effectiveness-implementation design. Veteran patients will be randomized to either the telehealth delivered CBT or usual care. Headache symptoms and severity will be reported using a VA text messaging application.
Detailed Description
With VHA's infrastructure dedicated to efficient telehealth delivery into patient homes, the delivery of a behavioral intervention for chronic migraine, CM, via the telehealth platform is primed to address barriers of in-person care delivery and holds considerable promise to reach and improve Veteran headache-related quality of life. Therefore, the goal is to evaluate an adapted bundle of EB implementation strategies to increase adoption of a Telemedicine-based Cognitive Behavioral Therapy (CBT) program (TENACITY) for CM in 2 VA HCoEs (VA Connecticut Healthcare System [VACHS], a large, multi-disciplinary HCoE, and Birmingham VA Medical Center [BVAMC], a smaller VA Headache Consortium Center. The HCoEs are charged with improving headache care throughout the VA, not just within an individual VAMC. As part of this study, a non-HCoE will also participate, providing an opportunity for the TENACITY study to extend this virtual specialty headache care to Veterans without headache specialty care. Dallas VA Medical Center, also known as the North Texas Health Care System [NTHCS] will participate as a third site. The investigators will determine whether TENACITY can be efficiently delivered through the vehicle of telehealth by conducting a pilot randomly controlled trial (RCT) comparing a) TENACITY to b) behavioral treatment as usual (TAU; i.e., behavioral usual care). The investigators will recruit Veterans diagnosed with chronic migraine during the one-year recruitment period across the 3 VAMCs. The investigators will randomize eligible Veterans to participate either in the TENACITY intervention (n=50) or treatment as usual (n=50). The specific aims are threefold: Aim 1: To develop a bundle of evidence-based practice (EBP) implementation strategies to engage 3 VA Medical Centers [2 Headache Centers of Excellence HCoEs and 1 general neurology service] and facilitate their local adaptation and implementation of Cognitive Behavioral Therapy (CBT) (TENACITY) through the vehicle of telehealth services. Hypothesis 1a. HCoE clinical providers will report high acceptability, appropriateness and fidelity of TENACITY at 3 months and maintenance at 6 months. Hypothesis 1b. TENACITY reach, adoption, and implementation will vary by HCoE local context as evaluated by the Consolidated Framework for Implementation Research (CFIR) inner settings. Aim 2. To conduct a pilot RCT and determine the preliminary efficacy and feasibility of TENACITY compared to TAU across 3 VA sites. Hypothesis 2: Veterans receiving TENACITY will experience a statistically significant reduction in routine clinical headache metrics: headache frequency [headache days per month] (primary outcome), headache-related impairment and psychological symptoms (secondary outcomes) compared to usual care at 3 and 6 months. Aim 3: The investigators will conduct exploratory cost analysis of TENACITY from the Veteran's perspective, using inputs from the pilot RCT, and a two-year budget impact analysis from the VHA's perspective, incorporating the costs of implementation as well as direct costs (and cost-savings,) of providing the TENACITY intervention over all HCoEs to VHA. Hypothesis 3: TENACITY will be cost-effective and provide value to Veterans and VHA.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Migraine Headache
Keywords
Implementation Science, Telehealth, Cognitive Behavioral Therapy

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a randomized, controlled feasibility pilot with a single intervention arm, and a usual care control arm. The intervention arm includes participation in the TENACITY telehealth cognitive behavioral therapy CBT program for headache plus education. The usual care arm includes behavioral treatment as usual which may include outpatient clinic-based health psychology in the VA or in the community, or mindfulness sessions by LCSW.
Masking
ParticipantOutcomes Assessor
Masking Description
The participant will be randomized by mode of delivery to the telehealth or TAU treatment stratified by site (VA Medical Center). Upon completion of the baseline evaluation, the project coordinator will assign random assignment. The research assistants will be masked to random assignment.
Allocation
Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TENACITY Telehealth Cognitive Behavioral Therapy for Migraine
Arm Type
Experimental
Arm Description
Six sessions of standardized Cognitive Behavioral Therapy for patients with diagnosed chronic migraine headaches will be delivered by a clinical health psychologist via telehealth platform. All patients have access to a set of standardized educational, headache self-management materials.
Arm Title
Behavioral Usual Care
Arm Type
Active Comparator
Arm Description
Behavioral usual care may include outpatient clinic-based health psychology in the VA or Community Care, or mindfulness sessions with LCSW. Behavioral usual care will be delivered by clinicians for patients with diagnosed chronic migraine.
Intervention Type
Behavioral
Intervention Name(s)
TENACITY Telehealth Cognitive Behavioral Therapy for Migraine
Intervention Description
Clinical health psychology therapy delivered via telehealth
Intervention Type
Behavioral
Intervention Name(s)
Behavioral Usual Care
Intervention Description
Behavioral usual care may include outpatient clinic-based health psychology in the VA or Community Care, or mindfulness sessions with LCSW.
Primary Outcome Measure Information:
Title
Number of Headache Days in the 30 days Prior to 3-Month Mark
Description
Daily self-reported migraine headaches using a VA text message protocol
Time Frame
30 days prior to 3-Month Outcomes after Baseline
Secondary Outcome Measure Information:
Title
Implementation fidelity to the core functions of TENACITY
Description
Degree to which the core components of TENACITY are delivered as intended
Time Frame
3 months
Title
Budget Impact Analysis
Description
Costs associated with program implementation
Time Frame
2 years
Other Pre-specified Outcome Measures:
Title
Migraine-Specific Quality of Life Questionnaire (MSQ)
Description
Self-reported migraine related functioning
Time Frame
3 and 6 months
Title
Migraine Disability Assessment (MIDAS)
Description
Self-reported disability due to migraines
Time Frame
3 and 6 months
Title
Headache-specific Pain Catastrophizing Scale (HPCS)
Description
Self-reported headache pain
Time Frame
3 and 6 months
Title
Headache Management Self-Efficacy Scale (HMSE)
Description
Self-reported confidence to manage headaches
Time Frame
3 and 6 months
Title
Personal Health Inventory short form
Description
Self-reported health
Time Frame
3 and 6 months
Title
PCL-5 (PTSD Checklist for DSM-5)
Description
Self-reported PTSD symptoms
Time Frame
3 and 6 months
Title
Patient Health Questionnaire - PHQ-9
Description
Self-reported depressive symptoms
Time Frame
3 and 6 months
Title
Generalized Anxiety Disorder (GAD-7)
Description
Self-reported anxiety symptoms
Time Frame
3 and 6 months
Title
Veterans RAND 12 (VR-12)
Description
Self-reported functioning and well-being
Time Frame
3 and 6 months
Title
Insomnia Severity Index (ISI)
Description
Self-reported sleep disruptions
Time Frame
3 and 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Veteran patients eligible to participate must have: A chronic migraine headache ICD-10 diagnosis; Completion of at least 28 headache diary days; A confirmed frequency of at least 8 headache days per month; A primary complaint of headache Exclusion Criteria: Veteran patients not eligible to participate include: Non-Veterans; Veteran patients without a CM headache ICD-10 diagnosis; Veteran patients whose primary pain complaint is not headache; Veteran patients who have received greater than or equal to 90 days of opioid therapy for chronic low back pain from the date of chart screening; Veteran patients who do not speak English; Veteran patients who have a current diagnosis of severe cognitive impairment indicated by clinical provider, medical chart, or Short Portable Mental Status Questionnaire (SPMSQ); Veteran patients who have Post Traumatic headache; Veteran patients who have a diagnosis of cluster headache, other primary headache, post-whiplash headache, secondary headache, or trigeminal autonomic cephalalgia. Any patients currently suffering from a disabling psychiatric illness (as noted by clinician); Veteran patients who self-report Traumatic Brain Injury less than or equal to 1 year before diagnosis of Chronic Migraine, or worsening of Chronic Migraine. Veteran patients who relate daily suicidal ideation within the last 2 weeks as indicated by the PHQ-9 with an answer of "3" to question nine; Veteran patients who have severe depression, as indicated by PHQ-9 score greater than or equal to 20; Veteran patients who are deemed by clinicians who are unable to participate in this trial; Patients who are terminally ill (life expectancy of <12 months as noted by clinician); Patients who are homeless or live in long-term care, nursing home, rehabilitation, or domiciliary services, etc. Veteran patients who decline to or cannot use the Annie App; Veteran patients who decline to or cannot use My HealtheVet secure messaging Veteran patients who have been treated by a HCoE clinical health psychologist in the last two years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Teresa M. Damush, PhD
Organizational Affiliation
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Official's Role
Principal Investigator
Facility Information:
Facility Name
Birmingham VA Medical Center, Birmingham, AL
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35233
Country
United States
Facility Name
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
City
West Haven
State/Province
Connecticut
ZIP/Postal Code
06516
Country
United States
Facility Name
Richard L. Roudebush VA Medical Center, Indianapolis, IN
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202-2884
Country
United States
Facility Name
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
City
Dallas
State/Province
Texas
ZIP/Postal Code
75216
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
After the study completion and the planned and secondary analyses are published by the study team, a limited de-identified data set will be made available upon request for a limited period.
IPD Sharing Time Frame
To be determined
Citations:
PubMed Identifier
35293614
Citation
Goldman RE, Damush TM, Kuruvilla DE, Lindsey H, Baird S, Riley S, Burrone Bs L, Grinberg AS, Seng EK, Fenton BT, Sico JJ. Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists. Headache. 2022 Mar;62(3):306-318. doi: 10.1111/head.14277. Epub 2022 Mar 16.
Results Reference
result
PubMed Identifier
36100439
Citation
Seng EK, Fenton BT, Wang K, Lipton RB, Ney J, Damush T, Grinberg AS, Skanderson M, Sico JJ. Frequency, Demographics, Comorbidities, and Health Care Utilization by Veterans With Migraine: A VA Nationwide Cohort Study. Neurology. 2022 Sep 13;99(18):e1979-92. doi: 10.1212/WNL.0000000000200888. Online ahead of print.
Results Reference
result

Learn more about this trial

TelemEdiciNe-bAsed Cognitive TherapY for Migraines

We'll reach out to this number within 24 hrs